Taken together, these results further support that the ABX-driven gut microbiome perturbation to Cyp1a1–/– mice negates the survival benefit and disrupts intestinal barrier integrity after MRSA-induced sepsis. The gene discussed is CYP1A1; the disease is Sepsis.